Introduction
The acronym POEMS syndrome' describes a complex multi-system disorder whose major features include polyneuropathy (P), organomegaly (0), endocrinopathy (E), monoclonal serum proteins (M) and skin changes (S). Typical cases were described as early as 1938 by Scheinker2 and later by Crow3 and Fukase.4 In 1977 Takatsuki et al. 5 were able to compile a series of 32 cases from Japan and this series has recently been increased to include 102 reported Japanese cases.6 Outside Japan the syndrome appears to be much less common, but non-Japanese cases are increasingly reported.7
Confusion has arisen over the nomenclature of the syndrome, which has also been referred to as the P E P syndrome,8 Takatsuki 
